Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/07/2012EP2520303A1 Anti-wart pharmaceutical composition
11/07/2012EP2520302A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
11/07/2012EP2520301A2 Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome
11/07/2012EP2520300A1 Pharmaceutical composition for oral administration
11/07/2012EP2520299A1 Solid pharmaceutical composition for oral administration
11/07/2012EP2520298A1 Pharmaceutical composition comprising sulfonylureas (glibenclamide) or meglitinides for use for treating hyperglycaemia or for promoting growth of a premature infant
11/07/2012EP2520297A1 Rubreserine and its derivates with antiparasitic activity
11/07/2012EP2520296A1 New association between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it.
11/07/2012EP2520295A1 Methods for preventing and treating mucositis
11/07/2012EP2520294A2 Composition including naphthoquinone compound for treating and preventing hearing loss
11/07/2012EP2520293A1 Compounds for use in the treatment of filariasis
11/07/2012EP2520292A1 Use of spirangiens for the treatment or prevention of IL-8 or IL-6 mediated disorders
11/07/2012EP2520291A1 Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease
11/07/2012EP2520290A1 Propofol analogs, process for their preparation, and methods of use
11/07/2012EP2520289A1 Norethisterone-containing patch
11/07/2012EP2520287A1 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
11/07/2012EP2520286A1 Pharmaceutical compositions of rhein or diacerein
11/07/2012EP2520285A1 Pharmaceutical compositions of rhein or diacerein
11/07/2012EP2520284A1 Pharmaceutical compositions of rhein or diacerein
11/07/2012EP2520283A1 Pharmaceutical compositions of rhein or diacerein
11/07/2012EP2520183A1 Use of agents containing Hydroxystilbene for preventing and/or treating illnesses
11/07/2012EP2520177A1 Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
11/07/2012EP2520168A1 Targeted gene delivery for dendritic cell vaccination
11/07/2012EP2519634A2 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
11/07/2012EP2519633A2 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/07/2012EP2519632A2 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
11/07/2012EP2519527A1 Thieno [2,3-b]pyridinedione activators of ampk and therapeutic uses thereof
11/07/2012EP2519526A1 Tricyclic compounds for use as kinase inhibitors
11/07/2012EP2519525A2 Substituted pyrrolo-aminopyrimidine compounds
11/07/2012EP2519524A1 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
11/07/2012EP2519522A2 Substituted imidazopyridinyl-aminopyridine compounds
11/07/2012EP2519521A1 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
11/07/2012EP2519520A1 [4-(3-aminomethyl-phenyl)-piperidin-1-yl]-(1h-pyrrolopyridinyl)-methanone derivatives as tryptase inhibitors
11/07/2012EP2519519A2 Substituted naphthalenyl-pyrimidine compounds
11/07/2012EP2519518A2 Imatinib dichloroacetate and anti-cancer agent comprising the same
11/07/2012EP2519517A2 Type ii raf kinase inhibitors
11/07/2012EP2519515A1 Pyrazine derivatives and their use in the treatment of neurological disorders
11/07/2012EP2519514A2 Alpha4beta2 neuronal nicotinic acetylcholine receptor ligands
11/07/2012EP2519513A1 Diacylglycerol based alpha-lipoic acid derivatives as antioxidants and agents for blocking food intake
11/07/2012EP2519511A1 Novel piperine derivatives as gaba - a receptors modulators
11/07/2012EP2519508A2 Metalloenzyme inhibitor compounds
11/07/2012EP2519507A1 Amino alcohol derivatives and their therapeutic activities
11/07/2012EP2519506A1 Hepatitis c virus inhibitors
11/07/2012EP2519505A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
11/07/2012EP2519504A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives.
11/07/2012EP2519503A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
11/07/2012EP2519501A2 Substituted pyridines and pyrimidines for the production of cardiomyocyte-like cells
11/07/2012EP2519499A1 Pesticidal arylpyrrolidines
11/07/2012EP2519300A1 System for treating target ti s sue within the eustachian tube
11/07/2012EP2519264A1 Taste masked dosage forms of bitter tasting anti-retroviral drugs
11/07/2012EP2519261A1 Oral liquid pharmaceutical composition of nifedipine
11/07/2012EP2519243A2 Compositions and methods for treating hepatitis b virus infection
11/07/2012EP2519242A1 Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases
11/07/2012EP2519241A2 Methods for treating autism
11/07/2012EP2519240A2 Pharmaceutical composition comprising metformin and rosuvastatin
11/07/2012EP2519239A1 Methods for enhancing natural killer cell proliferation and activity
11/07/2012EP2519238A1 Beta-carbolines for use in the treatment of hearing loss and vertigo
11/07/2012EP2519237A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
11/07/2012EP2519236A2 MOLECULES RELATED hERG Ion CHANNELS AND THE USE THEREOF
11/07/2012EP2519235A1 Heteroaryl compounds and uses thereof
11/07/2012EP2519234A1 Anaplerotic therapy for alzheimer's disease and the aging brain
11/07/2012EP2519233A1 Pharmaceutical composition for treating alcohol dependency
11/07/2012EP2519232A1 Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
11/07/2012EP2519231A2 Treatment of disease with proteasome inhibitors background of the invention
11/07/2012EP2519230A2 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
11/07/2012EP2519227A2 Management of myoclonus with oral liposomal reduced glutathione
11/07/2012EP2519226A1 Orally administrable film dosage forms containing ondansetron
11/07/2012EP2519225A1 Melt extruded nicotine thin strips
11/07/2012EP2519217A2 Use of skin permeation and retention enhancer compound in cosmetic and pharmaceutical compositions and cosmetic and pharmaceutical products containing said compound
11/07/2012EP2519115A1 Compositions including pyruvate for companion animals and methods of use thereof
11/07/2012EP2519114A1 Compositions including pyruvate for companion animals and methods of use thereof
11/07/2012EP2519108A1 Compositions and method for treatment and prophylaxis of inflammatory bowel disease
11/07/2012EP2519102A2 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/07/2012EP2519101A1 Amino acid conjugates of quetiapine, process for making and using the same
11/07/2012EP2213737B1 Double-stranded oligonucleotides
11/07/2012DE20321906U1 Pramipexol-Dosierform zur einmal täglichen Verabreichung Pramipexole dosage for once daily administration
11/07/2012DE202012007199U1 Intrathekale pharmazeutische Baclofen-Dosierungsformen und dazugehöriges Abgabesystem Intrathecal baclofen pharmaceutical dosage forms and associated delivery system
11/07/2012DE202012003160U1 Clock Genexpression regulierendes Mittel Clock gene expression regulating agent
11/07/2012CN1988886B Heat sterilization of glucocorticosteroids
11/07/2012CN1985827B Compound ciprofloxacin injection for animal and its preparing process
11/07/2012CN1943585B Breviscapine proliposome powder preparation
11/07/2012CN1911960B Chlamydia protein, gene sequence and uses thereof
11/07/2012CN1880301B Tiopronin lysine and its preparing process and use
11/07/2012CN1871240B Pyrrolopyrimidine thion derivatives
11/07/2012CN1839826B Oral formulation for twice-daily administration
11/07/2012CN1832929B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/07/2012CN1777416B Lactate containing pharmaceutical composition and uses thereof
11/07/2012CN1744901B Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis
11/07/2012CN1524088B A virus causing respiratory tract illness in susceptible mammals
11/07/2012CN102770561A Tissue-based micro-RNA methods for diagnosis of different subtypes of lung cancer
11/07/2012CN102770560A Plasma-based micro-RNA biomarkers and methods for early detection of colorectal cancer
11/07/2012CN102770540A Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
11/07/2012CN102770435A Pyrazolopyrimidine compounds and their use as PDE10 inhibitors
11/07/2012CN102770434A Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
11/07/2012CN102770431A [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1H-pyrrolo-pyridin-yl)-methanones and synthesis thereof
11/07/2012CN102770429A Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
11/07/2012CN102770426A Compounds and compositions as protein kinase inhibitors
11/07/2012CN102770425A Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
11/07/2012CN102770423A Preparation process of the sodium salt of esomeprazole
11/07/2012CN102770421A Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
1 ... 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 ... 7860